XALOX RTU oxaliplatin 200mg/40mL concentrated solution for injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

oxaliplatin, Quantity: 200 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

Oxaliplatin

forme pharmaceutique:

Injection, concentrated

Composition:

Excipient Ingredients: lactose monohydrate; water for injections

Mode d'administration:

Intravenous Infusion

Unités en paquet:

1 vial

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: ,? Adjuvant treatment of stage III (Duke?s C) colon cancer after complete resection of ,the primary tumour ,? Treatment of advanced colorectal cancer

Descriptif du produit:

Visual Identification: Clear, colourless to slightly yellow solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2011-12-12